BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23597718)

  • 1. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria.
    Paulke-Korinek M; Kollaritsch H; Aberle SW; Zwazl I; Schmidle-Loss B; Vécsei A; Kundi M
    Vaccine; 2013 May; 31(24):2686-91. PubMed ID: 23597718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
    Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
    Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012).
    Costantino C; Restivo V; Cuccia M; Furnari R; Amodio E; Vitale F
    Ital J Pediatr; 2015 Aug; 41():52. PubMed ID: 26232152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.
    Linhares AC; Justino MC
    Expert Rev Vaccines; 2014 Jan; 13(1):43-57. PubMed ID: 24308577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal Mass Vaccination Against Rotavirus: Indirect Effects on Rotavirus Infections in Neonates and Unvaccinated Young Infants Not Eligible for Vaccination.
    Prelog M; Gorth P; Zwazl I; Kleines M; Streng A; Zlamy M; Heinz-Erian P; Wiedermann U
    J Infect Dis; 2016 Aug; 214(4):546-55. PubMed ID: 27190178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009.
    Yen C; Tate JE; Steiner CA; Cortese MM; Patel MM; Parashar UD
    J Infect Dis; 2012 Jul; 206(1):41-8. PubMed ID: 22539812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
    Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
    Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections.
    Zlamy M; Kofler S; Orth D; Würzner R; Heinz-Erian P; Streng A; Prelog M
    BMC Infect Dis; 2013 Mar; 13():112. PubMed ID: 23452879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel.
    Muhsen K; Rubenstein U; Kassem E; Goren S; Schachter Y; Kremer A; Shulman LM; Ephros M; Cohen D
    Hum Vaccin Immunother; 2015; 11(10):2475-82. PubMed ID: 26212174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accounting for indirect protection in the benefit-risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018.
    Escolano S; Mueller JE; Tubert-Bitter P
    Euro Surveill; 2020 Aug; 25(33):. PubMed ID: 32820718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Weinberg GA; Hall CB; Chappell J; Curns AT; Wikswo M; Tate JE; Lopman BA; Parashar UD;
    Clin Infect Dis; 2011 Aug; 53(3):245-53. PubMed ID: 21705316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccines: a story of success.
    Kollaritsch H; Kundi M; Giaquinto C; Paulke-Korinek M
    Clin Microbiol Infect; 2015 Aug; 21(8):735-43. PubMed ID: 25680314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of rotavirus vaccination in the prevalence of gastroenteritis and comorbidities among children after suboptimal rotavirus vaccines implementation in Taiwan: A population-based study.
    Lu MC; Shia BC; Kao YW; Lin SC; Wang CY; Lin WC; Chen SY
    Medicine (Baltimore); 2021 Jun; 100(25):e25925. PubMed ID: 34160381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.
    Orrico-Sanchez A; López-Lacort M; Pérez-Vilar S; Díez-Domingo J
    BMC Infect Dis; 2017 Apr; 17(1):267. PubMed ID: 28399824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?
    Matthijnssens J; Nakagomi O; Kirkwood CD; Ciarlet M; Desselberger U; Van Ranst M
    Expert Rev Vaccines; 2012 Nov; 11(11):1347-54. PubMed ID: 23249234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intussusception among Norwegian children: What to expect after introduction of rotavirus vaccination?
    Bruun T; Watle SSV; Tveteraas IH; Flem E
    Vaccine; 2019 Sep; 37(38):5717-5723. PubMed ID: 31255303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intussusception Rate Among Under-Five-Children Before Introduction of Rotavirus Vaccine in North India.
    Gupta M; Kanojia R; Singha R; Tripathy JP; Mahajan K; Saxena A; Bansal A; Muralidharan J; Kumar R
    J Trop Pediatr; 2018 Aug; 64(4):326-335. PubMed ID: 29040742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.